CPA
CNCR

Clear Point Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Clear Point Advisors’s Portfolio CNCR Stock Details CNCR Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27
Closed -$403 – 194
2024
Q3 		$403 Hold
27
– – ﹤0.01% 512
2024
Q2 		$364 Hold
27
– – ﹤0.01% 511
2024
Q1 		$448 Hold
27
– – ﹤0.01% 501
2023
Q4 		$363 Buy
+27
New +$363 ﹤0.01% 499